You have 9 free searches left this month | for more free features.

irbesartan

Showing 1 - 25 of 59

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine FDC, Irbesartan, Amlodipine)

Active, not recruiting
  • Healthy Volunteers
  • Irbesartan/Amlodipine FDC
  • +2 more
  • Seoul, Korea, Republic of
    H Plus Yangji Hospital
Jan 8, 2023

Healthy Volunteers Trial in Seoul (Irbesartan/Amlodipine High FDC, Irbesartan, Amlodipine High)

Active, not recruiting
  • Healthy Volunteers
  • Irbesartan/Amlodipine High FDC
  • +2 more
  • Seoul, Korea, Republic of
    H Plus Yangji Hospital
Jan 8, 2023

Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine low, Irbesartan/Amlodipine high, Irbesartan)

Recruiting
  • Essential Hypertension
  • Irbesartan/Amlodipine low
  • +2 more
  • Seoul, Korea, Republic of
    Severance Hospital
Jul 24, 2022

Essential Hypertension Trial in Seoul (Irbesartan/Amlodipine, Irbesartan)

Recruiting
  • Essential Hypertension
  • Seoul, Korea, Republic of
    Hanyang University Seoul Hospital
Jul 24, 2022

Bariatric Surgery and Pharmacokinetics of Irbesartan

Recruiting
  • Obesity, Morbid
  • Irbesartan
  • Trondheim, Norway
    St. Olavs University Hospital
Apr 1, 2022

Hypertension Trial in Edinburgh, London, Manchester (ALN-AGT01, ALN-AGT01-Matching Placebo, Irbesartan)

Completed
  • Hypertension
  • Edinburgh, United Kingdom
  • +2 more
Jan 13, 2023

CKD5 Stage Dialysis, Heart Failure Trial in Shanghai (Sacubitril/Valsartan, Irbesartan)

Recruiting
  • CKD5 Stage Dialysis
  • Heart Failure
  • Shanghai, Shanghai, China
    Department of Nephrology, Ruijin Hospital, School of Medicine, S
Feb 20, 2022

Diabetic Nephropathy Trial in Naples (SoC therapy, irbesartan, ramipril)

Completed
  • Diabetic Nephropathy
  • SoC therapy
  • +13 more
  • Naples, Italy
    Department of Advanced Medical and Surgical Sciences, Università
Jul 31, 2020

Type 2 Diabetic Nephropathy Trial in Changsha, Chenzhou, Yiyang (Alfacalcidol, Irbesartan)

Completed
  • Type 2 Diabetic Nephropathy
  • Changsha, Hunan, China
  • +2 more
Oct 9, 2019

Ehlers-Danlos Syndrome, Vascular Type Trial in France (Irbesartan, Placebo)

Completed
  • Ehlers-Danlos Syndrome, Vascular Type
  • Irbesartan
  • Placebo
  • Bordeaux, France
  • +14 more
Nov 2, 2020

Focal Segmental Glomerulosclerosis Trial in Worldwide (sparsentan, Irbesartan)

Active, not recruiting
  • Focal Segmental Glomerulosclerosis
  • Mesa, Arizona
  • +224 more
Oct 27, 2022

IgA Nephropathy Trial in Guangzhou (irbesartan, methylprednisolone (MP) or prednisone (pred), mycophenolate mofetil (MMF))

Completed
  • IgA Nephropathy
  • irbesartan
  • +2 more
  • Guangzhou, Guangdong, China
    The 1st Affiliated Hospital, Sun Yet-sen University
Dec 1, 2019

Hypertension, Obesity, Stress, Psychological Trial in Augusta (Irbesartan, Placebo)

Unknown status
  • Hypertension
  • +3 more
  • Irbesartan
  • Placebo
  • Augusta, Georgia
    Augusta University
Jun 19, 2019

Renal Insufficiency, Chronic, Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Placebo, Lisinopril)

Recruiting
  • Renal Insufficiency, Chronic
  • Hyperkalemia
  • Sodium Zirconium Cyclosilicate (SZC)
  • +4 more
  • Tucson, Arizona
  • +281 more
Jan 10, 2023

Obesity and Glomerulopathy Trial in Nanjing (High dosage Sevelamer Carbonate + Irbesartan, Low dosage Sevelamer Carbonate +

Terminated
  • Obesity and Glomerulopathy
  • High dosage Sevelamer Carbonate + Irbesartan
  • +2 more
  • Nanjing, Jiangsu, China
    Research Institute of Nephrology, Jinling Hospital, Nanjing Univ
Sep 29, 2018

Preeclampsia, Pregnancy Induced Hypertension Trial in Boston (Irbesartan)

Suspended
  • Preeclampsia
  • Pregnancy Induced Hypertension
  • Irbesartan
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 15, 2019

Hypertension Trial in San Antonio (Irbesartan, Avapro)

Completed
  • Hypertension
  • San Antonio, Texas
    Worldwide Clinical Trials Drug Development Solutions (formerly C
Jan 19, 2018

Hypertension Trial in San Antonio (Irbesartan, Avapro)

Completed
  • Hypertension
  • San Antonio, Texas
    Worldwide Clinical Trials Drug Development Solutions (formerly C
Jan 19, 2018

Kidney Transplantation Trial in Canada (tacrolimus, Simulect, Cellcept)

Completed
  • Kidney Transplantation
  • Calgary, Alberta, Canada
  • +12 more
Apr 3, 2019

Hypertension Trial in Investigative Centers, Basel (valsartan, irbesartan)

Completed
  • Hypertension
  • Investigative Centers, Germany
  • +1 more
May 16, 2017

Hypertension Trial in Stockholm (Irbesartan, Atenolol)

Completed
  • Hypertension
  • Stockholm, Sweden
    Karolinska Institutet, Daprtment of Clinical Sciences, Danderyd
May 3, 2015

Healthy Trial in Seoul (Gemigliptin, Irbesartan)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 29, 2014

CHF Trial in Worldwide (Irbesartan, Placebo)

Completed
  • Congestive Heart Failure
  • Irbesartan
  • Placebo
  • Birmingham, Alabama
  • +230 more
Mar 18, 2015

Obesity, Hypertension Trial in Thessaloniki (Irbesartan, Amlodipine)

Withdrawn
  • Obesity
  • Hypertension
  • Thessaloniki, Greece
    Hypertension-24h ABPM Center Papageorgiou Hospital
Feb 10, 2014

Hepatitis C, Chronic Trial in Angers (Irbesartan, )

Completed
  • Hepatitis C, Chronic
  • Irbesartan
  • placebo
  • Angers, France
    CHU Angers, Service d'hépato-gastroentérologie
Feb 6, 2014